Retreatment of Hepatitis C Virus Among People Who Inject Drugs
After reinfection or not achieving SVR with the first DAA regimen, retreated PWID achieved higher SVR rates than with initial DAA treatment. To attain HCV elimination and benefit individual and public health, assisting PWID with accessing prompt retreatment is crucial.
Authors
- Arthur Y. Kim (ORCID: https://orcid.org/0000-0003-4712-2657)
- Cristina Murray‐Krezan (ORCID: https://orcid.org/0000-0002-5488-1080)
- Brianna L. Norton (ORCID: https://orcid.org/0000-0002-8287-2245)
- Shruti H. Mehta (ORCID: https://orcid.org/0000-0002-2523-0959)
- Paula J. Lum (ORCID: https://orcid.org/0000-0002-0833-8642)
- Moonseong Heo (ORCID: https://orcid.org/0000-0001-7711-1209)
- Judith Feinberg (ORCID: https://orcid.org/0000-0003-4206-7214)
- Julia Hope Arnsten (ORCID: https://orcid.org/0000-0002-7741-1567)
- Karen T. Tashima (ORCID: https://orcid.org/0000-0002-1211-3120)
- Emily A. Waters (ORCID: https://orcid.org/0000-0003-3479-6054)
- Kendra L. Blalock
- Aurielle Thomas
- Alain H. Litwin (ORCID: https://orcid.org/0000-0002-6717-0288)
- Ellen Stein (ORCID: https://orcid.org/0000-0003-3864-4891)
- Judith I. Tsui (ORCID: https://orcid.org/0000-0003-0877-5399)
- Sophie Sprecht-Walsh (ORCID: https://orcid.org/0009-0001-0023-1592)
- Lynn E. Taylor (ORCID: https://orcid.org/0000-0002-0472-8125)
- Kimberly Ann Page (ORCID: https://orcid.org/0000-0002-7120-1673)
- Megan Groome
Institutions
- West Virginia University (US)
- Prisma Health (US)
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
- Harvard University (US)
- Johns Hopkins University (US)
- University of South Carolina (US)
- University of New Mexico (US)
- University of Pittsburgh (US)
- University of Rhode Island (US)
- University of California, San Francisco (US)
- Providence College (US)
- University of Washington (US)
- Brown University (US)
- Miriam Hospital (US)
- Massachusetts General Hospital (US)
- Clemson University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1093/cid/ciaf082
- Citations
- 4
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 5.29
Funders
- Gilead Sciences
- Patient-Centered Outcomes Research Institute
- Quest Diagnostics